COVID-19-A vascular disease

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) leads to multi-system dysfunction with emerging evidence suggesting that SARS-CoV-2-mediated endothelial injury is an important effector of the virus. Potential therapies that address vascular system dysfunction and its sequelae may have an important role in treating SARS-CoV-2 infection and its long-lasting effects. (C) 2020 Elsevier Inc. All rights reserved.

Automated summary

SARS-CoV-2 causes multi-system dysfunction, with emerging evidence indicating that endothelial injury plays a crucial role. Therapies targeting vascular system dysfunction may be important in treating SARS-CoV-2 infection and its long-lasting effects.